[{"Assets_0_Q2_USD":69538532.0,"CommonStockSharesOutstanding_0_Q2_shares":38833507.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":6598635.0,"NetIncomeLoss_1_Q2_USD":-5989991.0,"NetIncomeLoss_2_Q2_USD":-13415523.0,"StockholdersEquity_0_Q2_USD":47906408.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":1333333.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":1333333.0,"Ticker":"AADI","CIK":"1422142","name":"AERPIO PHARMACEUTICALS, INC.","OfficialName":"Aadi Bioscience Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"339479977.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180814"}]